Mylan, IRS Ink Deal To Avoid Trial On Nebivolol Transaction
By Jimmy Hoover · May 24, 2017, 4:23 PM EDT
Mylan Inc. and the IRS have struck a last-minute deal to avert a $100 million tax trial relating to the drugmaker's transaction with Forest Laboratories Holdings Ltd. over the antihypertensive compound...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login